Ευρωπαϊκή Ένωση -
Σουηδικά -
EMA (European Medicines Agency)
koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastiska medel - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
Ευρωπαϊκή Ένωση -
Σουηδικά -
EMA (European Medicines Agency)
tessie
orion corporation - tasipimidine sulfate - other hypnotics and sedatives - hundar - alleviation of situational anxiety and fear in dogs triggered by e. travel, noise, owner departure, veterinary visits.
Ευρωπαϊκή Ένωση -
Σουηδικά -
EMA (European Medicines Agency)
pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
dexatin 10 mg tablett
abboxia ab - dexamfetaminsulfat - tablett - 10 mg - dexamfetaminsulfat 10 mg aktiv substans; isomalt hjälpämne
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
dexatin 20 mg tablett
abboxia ab - dexamfetaminsulfat - tablett - 20 mg - dexamfetaminsulfat 20 mg aktiv substans; isomalt hjälpämne
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
dexatin 5 mg tablett
abboxia ab - dexamfetaminsulfat - tablett - 5 mg - dexamfetaminsulfat 5 mg aktiv substans; isomalt hjälpämne
